Vakzine Projekt Management GmbH clinical trials

Acquired by Serum Institute of India Pvt. Ltd.

The registry lists 4 studies whose lead sponsor is Vakzine Projekt Management GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2021.

Status

Completed: 4

Phase

Phase 1: 2
Phase 3: 1
Phase 2: 1

Where

South Africa: 2
Germany: 2

Registry sponsor names on this page

Vakzine Projekt Management GmbH4 studies

Something wrong with this grouping? Tell us on the Serum Institute of India Pvt. Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 4 of 4. All Serum Institute of India Pvt. Ltd. studies →

Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 PandemicCompletedNCT04435379Phase 3
Sponsor listed in the registry: Vakzine Projekt Management GmbH · Vakzine Projekt Management GmbH — acquired company within the Serum Institute of India Pvt. Ltd. group
Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South AfricaCompletedNCT01479972Phase 2
Sponsor listed in the registry: Vakzine Projekt Management GmbH · Vakzine Projekt Management GmbH — acquired company within the Serum Institute of India Pvt. Ltd. group
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South AfricaCompletedNCT01113281Phase 1
Sponsor listed in the registry: Vakzine Projekt Management GmbH · Vakzine Projekt Management GmbH — acquired company within the Serum Institute of India Pvt. Ltd. group
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male VolunteersCompletedNCT00749034Phase 1
Sponsor listed in the registry: Vakzine Projekt Management GmbH · Vakzine Projekt Management GmbH — acquired company within the Serum Institute of India Pvt. Ltd. group